Literature DB >> 2044580

Copper and liver disease.

D M Danks1.   

Abstract

There has been some limited progress in the understanding of the basic defect in Wilson disease and the gene concerned has been located to the chromosome region 13q14. Treatment with zinc has emerged as a definite alternative to penicillamine administration and some shortcomings and/or hazards of both forms of therapy have emerged as their modes of action have been studied more carefully. Tetrathimolybdate may have a place in treatment, especially when rapid complexing of copper is important. Hepatic copper accumulation occurs in a number of cholestatic diseases and they play an important part in pathogenesis and can occasionally lead to neurologic toxic effects. Copper overload in the newborn period when biliary excretion of copper is inefficient may establish a vicious cycle of copper accumulation and liver damage in Indian childhood cirrhosis and less frequently in babies in other countries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044580     DOI: 10.1007/bf01963553

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

1.  Can Wilson's disease patients be decoppered?

Authors:  J Mason; A McQuaid; H Pheiffer
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

2.  Wilson's disease patients can be decoppered.

Authors:  J M Walshe
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

3.  Predicting genotypes at loci for autosomal recessive disorders using linked genetic markers: application to Wilson's disease.

Authors:  L A Farrer; B Bonne-Tamir; M Frydman; A Magazanik; K K Kidd; A M Bowcock; L L Cavalli-Sforza
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

4.  Hereditary recurrent cholestasis with lymphoedema--two new families.

Authors:  O Aagenaes
Journal:  Acta Paediatr Scand       Date:  1974-05

5.  Prognosis of babies with neonatal hepatitis.

Authors:  D M Danks; P E Campbell; A L Smith; J Rogers
Journal:  Arch Dis Child       Date:  1977-05       Impact factor: 3.791

6.  Wilson's disease: clinical presentation and use of prognostic index.

Authors:  H Nazer; R J Ede; A P Mowat; R Williams
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

7.  Ascorbate enhances copper transport from ceruloplasmin into human K562 cells.

Authors:  S S Percival; E D Harris
Journal:  J Nutr       Date:  1989-05       Impact factor: 4.798

8.  Idiopathic hepatic copper toxicosis in a child.

Authors:  G Maggiore; C De Giacomo; F Sessa; G R Burgio
Journal:  J Pediatr Gastroenterol Nutr       Date:  1987 Nov-Dec       Impact factor: 2.839

9.  Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.

Authors:  V Iyengar; G J Brewer; R D Dick; O Y Chung
Journal:  J Lab Clin Med       Date:  1988-03

10.  Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin.

Authors:  M Tavassoli; T Kishimoto; M Kataoka
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

View more
  4 in total

1.  WILSON'S DISEASE (A report of two cases).

Authors:  M Kanitkar; S N JOSHi; N Dutta Roy
Journal:  Med J Armed Forces India       Date:  2017-06-27

Review 2.  Hepatic disorders. Features and appropriate management.

Authors:  M A Aldersley; J G O'Grady
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

3.  Copper associated childhood cirrhosis.

Authors:  S P Horslen; M S Tanner; T D Lyon; G S Fell; M F Lowry
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

4.  Case report: concordant traumatic brainstem contusion delayed diagnosis in a young man with Wilson's disease.

Authors:  A Marcus; C Ammermann; M Klein; M H Schmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  1995-01       Impact factor: 4.785

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.